Parathyroid Cancer — Trials

Parathyroid Cancer — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Instituto do Cancer do Estado de São Paulo
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03280264	Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism	completed	Phase 3	18	Kyowa Kirin Co., Ltd.INDUSTRY	1	May 27, 2021	clinicaltrials
NCT01460030	An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism	completed	Phase 3	—	Kyowa Kirin Co., Ltd.INDUSTRY	1	Mar 3, 2017